Reported Dec 31, 2025 · Ongoing

Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme…

Merck Sharp & Dohme LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Merck Sharp & Dohme LLC · 4633 Merck Rd W · Wilson, NC · 27893-9613

Is this the product you have?

  • Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only
  • Manufactured forMerck Sharpe & Dohme LLC, Rahway, NJ 07065, USA
  • Manufactured byNovo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Lot codes and dates
    • Lot #: Z014503
    • Exp 11/15/2027
Amount recalled
3 - single dose kits

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Where it was sold

  • Nationwide

Why it was recalled

Presence of particulate matter: potential presence of metal particulates in the product.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Merck Sharp & Dohme LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 6:38 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.